These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32867730)

  • 21. Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges.
    Delhaes L; Frealle E; Pinel C
    Med Mycol; 2010 Nov; 48 Suppl 1():S77-87. PubMed ID: 21067334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
    Kraemer R; Deloséa N; Ballinari P; Gallati S; Crameri R
    Am J Respir Crit Care Med; 2006 Dec; 174(11):1211-20. PubMed ID: 16959918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    Mroueh S; Spock A
    Chest; 1994 Jan; 105(1):32-6. PubMed ID: 8275769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic bronchopulmonary aspergillosis presenting as lobar or total lung collapse.
    Kumar R; Poongadan MN; Singh M
    Pneumonol Alergol Pol; 2015; 83(2):144-50. PubMed ID: 25754057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing Total Serum IgE, Allergic Bronchopulmonary Aspergillosis, and Lung Function in Cystic Fibrosis.
    Gothe F; Kappler M; Griese M
    J Allergy Clin Immunol Pract; 2017; 5(6):1591-1598.e6. PubMed ID: 28526275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole.
    Nepomuceno IB; Esrig S; Moss RB
    Chest; 1999 Feb; 115(2):364-70. PubMed ID: 10027433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
    De Baets F; De Keyzer L; Van Daele S; Schelstraete P; Van Biervliet S; Van Braeckel E; Thomas M; Wanyama SS
    Pediatr Allergy Immunol; 2018 Nov; 29(7):726-731. PubMed ID: 29981532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An asthmatic child with allergic bronchopulmonary aspergillosis (ABPA).
    Özdemir Ö
    Turk J Pediatr; 2018; 60(4):446-452. PubMed ID: 30859774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF): clinical significance, diagnosis and therapy].
    Paul KD; Leupold W; Blaschke-Hellmessen R; Ulbrich K; Peter-Kern M; Neumeister V
    Mycoses; 1996; 39 Suppl 1():55-8. PubMed ID: 8767272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergic bronchopulmonary aspergillosis in two patients with cystic fibrosis.
    Anadol D; Ozçelik U; Kiper N; Göçmen A
    Turk J Pediatr; 2000; 42(1):68-71. PubMed ID: 10731875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
    Emiralioglu N; Dogru D; Tugcu GD; Yalcin E; Kiper N; Ozcelik U
    Ann Pharmacother; 2016 Mar; 50(3):188-93. PubMed ID: 26699090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological mechanisms behind the cystic fibrosis-ABPA link.
    Hartl D
    Med Mycol; 2009; 47 Suppl 1():S183-91. PubMed ID: 18651306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors for allergic bronchopulmonary aspergillosis in Indian children with cystic fibrosis.
    Sharma VK; Raj D; Xess I; Lodha R; Kabra SK
    Indian Pediatr; 2014 Apr; 51(4):295-7. PubMed ID: 24825267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergic bronchopulmonary aspergillosis (ABPA) sans asthma: A distinct subset of ABPA with a lesser risk of exacerbation.
    Muthu V; Sehgal IS; Prasad KT; Dhooria S; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
    Med Mycol; 2020 Feb; 58(2):260-263. PubMed ID: 31111905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Gernez Y; Waters J; Mirković B; Lavelle GM; Dunn CE; Davies ZA; Everson C; Tirouvanziam R; Silver E; Wallenstein S; Chotirmall SH; McElvaney NG; Herzenberg LA; Moss RB
    Eur Respir J; 2016 Jan; 47(1):177-85. PubMed ID: 26585435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
    Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
    Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.
    Knutsen AP; Hutcheson PS; Slavin RG; Kurup VP
    Allergy; 2004 Feb; 59(2):198-203. PubMed ID: 14763934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis.
    Skowronski E; Fitzgerald DA
    Med J Aust; 2005 May; 182(9):482-3. PubMed ID: 15865595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis.
    Thia LP; Balfour Lynn IM
    Paediatr Respir Rev; 2009 Mar; 10(1):37-42. PubMed ID: 19203743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
    Tanou K; Zintzaras E; Kaditis AG
    Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.